Start-Up Spotlight: OrthoSon Targets Back Pain With Ultrasound, Injectable Hydrogel Combo

The Oxford University spin-off has raised over £3m so far to develop its minimally invasive disc nucleus replacement technology and plans a £10m series A.

Start-up Spotlight

Nucleus pulposus implants that can alleviate pain and even reverse the disease process have long shown promise as a new option for treating deteriorated spinal discs, providing a long-term treatment option that avoided invasive surgical procedures such as disc replacement or spinal fusion.

Products being developed around 10 years ago included Disc Dynamics’ DASCOR disc arthroplasty device, an in-situ, curable polymer designed to replace the degenerated nucleus and restore the disc function. While...

One of these problems was the result of damage caused, during the surgery, to the annulus fibrosus, the strong outer ligamentous ring that surrounds the nucleus. This damage meant that...

More from R&D

More from Business

Edwards Lifesciences Holds 2025 EPS Outlook Despite Tariff Headwind

 
• By 

The brunt of the tariff exposure stems from Singapore and Costa Rica, which together account for an estimated 70% to 80% of the tariff-related cost burden. Less than 10% of the exposure is tied to China.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By 

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.